Canada markets open in 9 hours 20 minutes

Constellation Pharmaceuticals, Inc. (CNST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.80+1.60 (+6.35%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
64,499
95,501
66,459
48,769
32,617
Selling General and Administrative
18,131
29,346
19,596
12,475
6,471
Total Operating Expenses
82,630
124,847
86,055
61,244
39,088
Operating Income or Loss
-82,630
-124,847
-86,055
-61,244
-39,088
Interest Expense
3,169
2,862
2,115
228
901
Total Other Income/Expenses Net
-1,460
-1,460
-
-
4,443
Income Before Tax
-81,286
-126,318
-85,526
-59,925
-35,377
Income Tax Expense
63
39
24
-
-
Income from Continuing Operations
-81,286
-126,357
-85,550
-59,925
-35,377
Net Income
-81,286
-126,357
-85,550
-59,925
-35,377
Net Income available to common shareholders
-81,286
-126,357
-85,550
-59,925
-39,792
Basic EPS
-
-
-3.04
-5.00
-3.40
Diluted EPS
-
-
-3.04
-5.00
-3.40
Basic Average Shares
-
-
28,152
11,984
11,690
Diluted Average Shares
-
-
28,152
11,984
11,690
EBITDA
-
-122,812
-82,653
-59,135
-34,002